Ascher-Svanum, H.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

PMH10 TREATMENT PATTERNS PRIORTO INITIATING DEPOT TYPICAL ANTIPSYCHOTICS FOR NON-ADHERENT SCHIZOPHRENIA PATIENTS

X Peng, H Ascher-Svanum, D Faries, W Montgomery

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 74 KB

english, 2008

52

PMH6 OPTIMAL THRESHOLDS OF EARLY NON-RESPONSE TO ATYPICAL ANTIPSYCHOTICS: APPLICATION OF SIGNAL DETECTION ANALYSIS

H Ascher-Svanum, L Chen, V Stauffer, BJ Kinon, O Tomori, S Kollack-Walker

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 91 KB

english, 2008

53

PMH35 COST-EFFECTIVENESS OF ORALLY DISSOLVING OLANZAPINE TABLETS IN THE TREATMENT OF SCHIZOPHRENIA IN THE USA

H Ascher-Svanum, NM Furiak, RW Klein, LJ Smolen, PR Watson, AH Lawson

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 68 KB

english, 2008

54

PMH8 IMPROVED TREATMENT OUTCOMES FOLLOWING A SWITCH FROM RISPERIDONE TO OLANZAPINE IN A 1-YEAR NATURALISTIC STUDY OF SCHIZOPHRENIA PATIENTS IN JAPAN

W Ye, S Fujikoshi, N Nakahara, M Takahashi, H Ascher-Svanum

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 69 KB

english, 2010

55

PMH14 ALL-CAUSE TREATMENT DISCONTINUATION FOR OLANZAPINE COMPARED TO OTHER ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA: A META-ANALYSIS

K Soares-Weiser, L Bechard-Evans, AH Lawson, J Davis, H Ascher-Svanum

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 77 KB

english, 2010

56

PMH43 DECLINE IN THE RATE AND COST OF PSYCHIATRIC HOSPITALIZATION FOLLOWING INITIATION OF DEPOT ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA

X Peng, H Ascher-Svanum, D Faries, RR Conley

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 76 KB

english, 2010

57

PMH15 PREDICTORS OF FAVORABLE LONG-TERM OUTCOME IN THE TREATMENT OF SCHIZOPHRENIA

G Cuyun Carter, D Milton, D Faries, H Ascher-Svanum

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 76 KB

english, 2010

58

PMH51 THE COST-EFFECTIVENESS OF EARLY RESPONDERS VERSUS EARLY NON-RESPONDERS TO ATYPICAL ANTIPSYCHOTIC THERAPY

X Peng, H Ascher-Svanum, D Faries, VL Stauffer, S Kollack-Walker, BJ Kinon, JM Kane

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 94 KB

english, 2010

59

PMH10 LONG-TERM OUTCOMES AFTER SWITCHING FROM TYPICAL ANTIPSYCHOTICS TO OLANZAPINE AMONG SCHIZOPHRENIA PATIENTS IN JAPAN

W Ye, S Fujikoshi, N Nakahara, M Takahashi, H Ascher-Svanum

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 69 KB

english, 2010

60

PMH9 PATIENTS' EARLY PERCEPTIONS OF MEDICATIONS' BENEFITS PREDICT SUBSEQUENT RESPONSE IN THE TREATMENT OF SCHIZOPHRENIA

A Nyhuis, H Ascher-Svanum, D Faries, VL Stauffer, S Kollack-Walker, BJ Kinon, PJ Weiden

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 69 KB

english, 2010

61

PMH48 VALIDATING A COST-EFFECTIVENESS ANALYSIS COMPARING OLANZAPINE WITH ZIPRASIDONE IN THE TREATMENT OF SCHIZOPHRENIA

C Graham, J Mauskopf, AH Lawson, H Ascher-Svanum, D Bruhn, PR Watson

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 68 KB

english, 2010

62

PMH17 OUTCOME TRAJECTORIES IN THE LONG-TERM TREATMENT OF SCHIZOPHRENIA

D Milton, G Cuyun Carter, D Faries, H Ascher-Svanum

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 68 KB

english, 2010

63

PMH66 REASONS FOR CONTINUING OR DISCONTINUING OLANZAPINE IN THE TREATMENT OF SCHIZOPHRENIA FROM PATIENTS' AND CLINICIANS' PERSPECTIVES

J Chen, H Ascher-Svanum, MG Case, A Nyhuis, D Faries, G Phillips, DO Perkins, VP Hoffmann

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 79 KB

english, 2010

64

PMH21 COST-EFFECTIVENESS OF OLANZAPINE LONG-ACTING INJECTION IN THE TREATMENT OF NON-ADHERENCE PATIENTS WITH SCHIZOPHRENIA IN THE UNITED STATES

H Ascher-Svanum, NM Furiak, RW Klein, W Montgomery, LJ Smolen, AH Lawson, RR Conley

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 88 KB

english, 2009

65

PMH67 ORAL SUPPLEMENTATION AND CONCOMITANT MEDICATION IN THE TREATMENT OF SCHIZOPHRENIA WITH LONG-ACTING ATYPICAL ANTIPSYCHOTICS

H Ascher-Svanum, X Peng, W Montgomery, DE Faries, AH Lawson, M Witte, D Novick, N Jemiai, E Perrin

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 86 KB

english, 2009

66

PMH47 REASONS FOR DISCONTINUATION AND CONTINUATION OF ANTIPSYCHOTIC THERAPY FROM PATIENT AND CLINICIAN PERSPECTIVES

AW Nyhuis, H Ascher-Svanum, V Stauffer, BJ Kinon, DE Faries, GA Phillips, D Perkins

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 87 KB

english, 2009

67

PMH3 Olanzapine Long-Acting Injection for Schizophrenia: An Evaluation of Patient Functioning During 24 Weeks of Maintenance Therapy

D. Novick, H. Anand, H. Ascher-Svanum, J. Haro, J. Bertsch, Z. Cui, H. Detke, D. Mcdonnell, W. Montgomery

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 58 KB

english, 2011

68

PMH12 Risk of Relapse and Hospitalization in the 2-Year Open-Label Treatment of Outpatients with Schizophrenia Randomized to Olanzapine Long-Acting Injection or Oral Olanzapine

D. Novick, H. Ascher-Svanum, J. Bertsch, H. Detke, D. Mcdonnell, M. Witte, J. Haro

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 71 KB

english, 2011

69

PMH13 Differences Between Patients Undergoing Augmentation or Switching of Antipsychotic Medications During Treatment of Schizophrenia

H. Ascher-Svanum, A.J. Brnabic, T. Lawson, B.J. Kinon, V.L. Stauffer, P.D. Feldman, K. Kelin

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 58 KB

english, 2011

70

PMH5 Empirically-Driven Definitions of “Good” “Moderate” and “Poor” Levels of Functioning in the Treatment of Schizophrenia

H. Ascher-Svanum, D. Novick, J. Haro, J. Aguado, Z. Cui, H. Anand

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 58 KB

english, 2011

71

PMH4 Extent of Attaining and Maintaining Symptom Remission by Antipsychotic Medication in the Treatment of Chronic Schizophrenia: Evidence from the Catie Study

S.Z. Levine, J. Rabinowitz, H. Ascher-Svanum, D. Faries, T. Lawson

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 58 KB

english, 2011

72

The burden of depressive symptoms in the long-term treatment of patients with schizophrenia

Robert R. Conley, Haya Ascher-Svanum, Baojin Zhu, Douglas E. Faries, Bruce J. Kinon

Journal:

Schizophrenia Research

Year:

2007

Language:

english

File:

PDF, 169 KB

english, 2007

73

41 – Early onset of antipsychotic action in schizophrenia: A clinical marker discriminating active drug from placebo

T. Treuer, B.J. Kinon, L. Chen, J. Lambert, H. Ascher-Svanum, V. Stauffer, S. Kollack-Walker

Journal:

Schizophrenia Research

Year:

2008

Language:

english

File:

PDF, 62 KB

english, 2008

74

42 – Number needed to treat (NNT) for all-cause medication discontinuation from randomized controlled trials comparing olanzapine to other antipsychotics for the treatment of schizophrenia

T. Treuer, V. Stauffer, J. Karagianis, V. Sutton, H. Ascher-Svanum, M. Silva De Lima, V. Poole-Hoffmann, M. Tohen

Journal:

Schizophrenia Research

Year:

2008

Language:

english

File:

PDF, 73 KB

english, 2008

75

Optimal thresholds of early response to atypical antipsychotics: Application of signal detection methods

Lei Chen, Haya Ascher-Svanum, Virginia Stauffer, Bruce J. Kinon, Sara Kollack-Walker, Stephen Ruberg

Journal:

Schizophrenia Research

Year:

2009

Language:

english

File:

PDF, 716 KB

english, 2009

76

Challenging the assumption that improvement in functional outcomes is delayed relative to improvement in symptoms in the treatment of schizophrenia

Bruce J. Kinon, Lei Chen, Haya Ascher-Svanum, Virginia L. Stauffer, Sara Kollack-Walker, Wei Zhou, Shitij Kapur, John M. Kane, Dieter Naber

Journal:

Schizophrenia Research

Year:

2010

Language:

english

File:

PDF, 315 KB

english, 2010

77

DIFFERENCES BETWEEN EARLY RESPONDERS AND EARLY NON-RESPONDERS TO ATYPICAL ANTIPSYCHOTICS ON SYMPTOM AND FUNCTIONAL OUTCOMES IN THE TREATMENT OF SCHIZOPHRENIA

Bruce Kinon, Lei Chen, Virginia Stauffer, Haya Ascher-Svanum, Wei Zhou, Sara Kollack-Walker, John Kane, Shitij Kapur

Journal:

Schizophrenia Research

Year:

2010

Language:

english

File:

PDF, 70 KB

english, 2010

78

SOCIO‐DEMOGRAPHIC CHARACTERISTICS AND INITIAL TREATMENT DECISIONS FOR PATIENTS WITH SCHIZOPHRENIA AT RISK OF TREATMENT NON-ADHERENCE

Katarina Kelin, Richard Newton, Malina I. Simu, Liang-Jen Chuo, Raúl I. Escamilla, Renee E. Granger, Wendy Ye, Alan J.M. Brnabic, William Montgomery, Haya Ascher-Svanum, Jamie Karagianis

Journal:

Schizophrenia Research

Year:

2010

Language:

english

File:

PDF, 92 KB

english, 2010

79

DECLINE IN THE RATE AND COST OF PSYCHIATRIC HOSPITALIZATION FOLLOWING INITIATION OF DEPOT ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA

Xiaomei Peng, Haya Ascher-Svanum, Douglas Faries, Robert R. Conley

Journal:

Schizophrenia Research

Year:

2010

Language:

english

File:

PDF, 83 KB

english, 2010

80

VALIDATING AN INDUSTRY-SPONSORED MODEL COMPARING THE COST-EFFECTIVENESS OF ATYPICAL ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA

Christopher N. Graham, Josephine Mauskopf, Anthony H. Lawson, Haya Ascher-Svanum, David Bruhn, Peter R. Watson

Journal:

Schizophrenia Research

Year:

2010

Language:

english

File:

PDF, 76 KB

english, 2010

81

RELATIONSHIPS AMONG MULTIPLE OUTCOME MEASURES IN THE STUDY OF SCHIZOPHRENIA

Lei Chen, Glenn A. Phillips, Joseph Johnston, Virginia Stauffer, Bruce J. Kinon, Haya Ascher-Svanum, Sara Kollack-Walker, Paul Succop, Dieter Naber

Journal:

Schizophrenia Research

Year:

2010

Language:

english

File:

PDF, 67 KB

english, 2010

82

THE HETEROGENEITY OF ANTIPSYCHOTIC RESPONSE IN THE TREATMENT OF SCHIZOPHRENIA

Virginia L. Stauffer, Michael Case, Haya Ascher-Svanum, Robert Conley, Shitij Kapur, John M. Kane, Sara Kollack-Walker, Jayanthi Jacob, Bruce J. Kinon

Journal:

Schizophrenia Research

Year:

2010

Language:

english

File:

PDF, 87 KB

english, 2010

83

Trajectories of response to treatment with atypical antipsychotic medication in patients with schizophrenia pooled from 6 double-blind, randomized clinical trials

Virginia Stauffer, Michael Case, Sara Kollack-Walker, Haya Ascher-Svanum, Tamara Ball, Shitij Kapur, Bruce J. Kinon

Journal:

Schizophrenia Research

Year:

2011

Language:

english

File:

PDF, 514 KB

english, 2011

84

Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: Evidence from the CATIE study

Stephen Z. Levine, Jonathan Rabinowitz, Haya Ascher-Svanum, Douglas E. Faries, Anthony H. Lawson

Journal:

Schizophrenia Research

Year:

2011

Language:

english

File:

PDF, 267 KB

english, 2011

85

Treatment response trajectories and antipsychotic medications: Examination of up to 18 months of treatment in the CATIE chronic schizophrenia trial

Stephen Z. Levine, Jonathan Rabinowitz, Douglas Faries, Anthony H. Lawson, Haya Ascher-Svanum

Journal:

Schizophrenia Research

Year:

2012

Language:

english

File:

PDF, 597 KB

english, 2012

86

Corrigendum to "Trajectories of response to treatment with atypical antipsychotic medication in patients with schizophrenia pooled from 6 double-blind, randomized clinical trials" [Shizophr. Res. 130 (2011) 11–19]

Virginia Stauffer, Michael Case, Sara Kollack-Walker, Haya Ascher-Svanum, Tamara Ball, Shitij Kapur, Bruce J. Kinon

Journal:

Schizophrenia Research

Year:

2012

Language:

english

File:

PDF, 86 KB

english, 2012

87

The number of prescription drugs used by patients treated for schizophrenic or bipolar disorders

J.S. Kennedy, H. Ascher-Svanum, D. Lee, M. Haberman

Journal:

Schizophrenia Research

Year:

2003

Language:

english

File:

PDF, 130 KB

english, 2003

88

EARLY ONSET OF ANTIPSYCHOTIC ACTION IN SCHIZOPHRENIA: A CLINICAL MARKER DISCRIMINATING ACTIVE DRUG FROM PLACEBO

Bruce Kinon, Lei Chen, Jennifer Sniadecki, Haya Ascher-Svanum, Virginia Stauffer, Sara Kollack-Walker, Shitij Kapur

Journal:

Schizophrenia Research

Year:

2008

Language:

english

File:

PDF, 58 KB

english, 2008

89

OPTIMAL THRESHOLDS OF EARLY NON-RESPONSE TO ATYPICAL ANTIPSYCHOTICS: APPLICATION OF SIGNAL DETECTION ANALYSIS

Lei Chen, Haya Ascher-Svanum, Virginia Stauffer, Bruce Kinon, Oladapo Tomori, Sara Kollack-Walker

Journal:

Schizophrenia Research

Year:

2008

Language:

english

File:

PDF, 57 KB

english, 2008

90

COST-EFFECTIVENESS OF ORALLY DISSOLVING OLANZAPINE TABLETS IN THE TREATMENT OF SCHIZOPHRENIA IN THE USA

Haya Ascher-Svanum, Robert Klein, Nicolas Furiak, Lee Smolen

Journal:

Schizophrenia Research

Year:

2008

Language:

english

File:

PDF, 58 KB

english, 2008

91

COST-EFFECTIVENESS OF GENERIC RISPERIDONE VERSUS OLANZAPINE AND OTHER ANTIPSYCHOTICS IN STANDARD FORMULATIONS IN PATIENTS WITH SCHIZOPHRENIA IN THE USA

Robert Klein, Haya Ascher-Svanum, Nicolas Furiak, Lee Smolen, Anthony Lawson, Danielle Loosbrock

Journal:

Schizophrenia Research

Year:

2008

Language:

english

File:

PDF, 59 KB

english, 2008

92

TREATMENT PATTERNS PRIOR TO INITIATING DEPOT TYPICAL ANTIPSYCHOTICS FOR NON-ADHERENT SCHIZOPHRENIA PATIENTS

Peng Xiaomei, Haya Ascher-Svanum, Douglas Faries, William Mongomery

Journal:

Schizophrenia Research

Year:

2008

Language:

english

File:

PDF, 64 KB

english, 2008

93

PREDICTING RESPONSE TO RISPERIDONE TREATMENT THROUGH IDENTIFICATION OF EARLY-ONSET OF ANTIPSYCHOTIC DRUG ACTION IN SCHIZOPHRENIA

Bruce Kinon, Lei Chen, Virginia Stauffer, Haya Ascher-Svanum, Wei Zhou, Oladapo Tomori

Journal:

Schizophrenia Research

Year:

2008

Language:

english

File:

PDF, 76 KB

english, 2008

94

TREATMENT COMPLETION RATES OF OLANZAPINE AND RISPERIDONE IN LONG ACTING INJECTABLE FORMULATIONS FOR THE TREATMENT OF SCHIZOPHRENIA: A COMPARISON OF SINGLE ARM OPEN-LABEL STUDIES

Haya Ascher-Svanum, William Montgmery, Allen Brnabic, Anthony Lawson, Oladapo Tomori, Kristina Coleman, Libby Lynch, Peining Chen, Scott Andersen, David McDonnell

Journal:

Schizophrenia Research

Year:

2008

Language:

english

File:

PDF, 61 KB

english, 2008

95

Poster #207 LONG-TERM FUNCTIONAL IMPROVEMENTS IN THE 2-YEAR TREATMENT OF SCHIZOPHRENIA OUTPATIENTS WITH OLANZAPINE LONG-ACTING INJECTION

Haya Ascher-Svanum, Diego Novick, Josep M. Haro, Jordan Bertsch, David McDonnell, Holland Detke

Journal:

Schizophrenia Research

Year:

2012

Language:

english

File:

PDF, 69 KB

english, 2012

96

Poster #219 DIFFERENCES BETWEEN PATIENTS UNDERGOING AUGMENTATION OR SWITCHING OF ANTIPSYCHOTIC MEDICATIONS DURING TREATMENT OF SCHIZOPHRENIA

Virginia L. Stauffer, Haya Ascher-Svanum, Alan J.M. Brnabic, Anthony H. Lawson, Bruce J. Kinon, Peter D. Feldman, Katarina Kelin

Journal:

Schizophrenia Research

Year:

2012

Language:

english

File:

PDF, 73 KB

english, 2012

97

Poster #189 COMPARING SYMPTOM RESPONSE AMONG ANTIPSYCHOTIC MEDICATIONS IN CATIE

Stephen Z. Levine, Haya Ascher-Svanum, Douglas E. Faries, Anthony H. Lawson, Jonathan Rabinowitz

Journal:

Schizophrenia Research

Year:

2012

Language:

english

File:

PDF, 88 KB

english, 2012

98

Poster #120 LONG-TERM HEALTHCARE COSTS AND FUNCTIONAL OUTCOMES ASSOCIATED WITH LACK OF REMISSION IN SCHIZOPHRENIA

Virginia S. Haynes, Baojin Zhu, Virginia Stauffer, Bruce J. Kinon, Lei Xu, Haya Ascher-Svanum

Journal:

Schizophrenia Research

Year:

2012

Language:

english

File:

PDF, 84 KB

english, 2012

99

PMI17 METHODS FOR ASSESSING THE VALUE OF ANTIPSYCHOTIC TREATMENT: A NEW PERSPECTIVE FOR INTERPRETING SERVICE UTILIZATION

SL Tunis, H Ascher-Svanum, RA Browne, FP Wang, BJ Kinon

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 78 KB

english, 2002

100

PMH38 CLINICAL COMPARABILITY OF SCHIZOPHRENIA PATIENTS SERVED AT TWO PUBLIC SETTINGS: VETERANS AFFAIRS (VA) AND NON-VA MEDICAID

H Ascher-Svanum, B Zhu, MD Stensland

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 58 KB

english, 2002